In this report, the varicose vein treatment market is broadly segmented into mode of treatment, products, and region. Shift towards less-invasive treatment procedures, availability of advanced varicose vein treatment devices, huge burden of varicose vein cases in North America and Europe, improving patient compliance & reliability, growing healthcare expenditure, and rapid growth in aging population are the major drivers of the varicose vein treatment market.

Request for Sample PDF @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=22524107

The major players in the varicose vein treatment market Medtronic plc (Ireland); AngioDynamics, Inc. (U.S.); biolitec AG (Austria); Syneron Medical Ltd. (Israel); Lumenis Ltd. (Israel); Dornier MedTech GmbH (Germany); Energist Group (U.K.); Eufoton s.r.l. (Italy); Vascular Solutions, Inc. (U.S.); Quanta System S.p.A. (Italy); Sciton, Inc. (U.S.); Fotona d.o.o. (Slovenia); BTG plc (U.K.); and Merz Aesthetics (U.S.). Currently, the varicose vein treatment market is dominated by Medtronic plc followed by AngioDynamics, Inc. and biolitec AG. Moreover, Medtronic is expected to maintain its leadership position in the varicose vein treatment market during the forecast period due to recently launched innovative products and strategic acquisitions to strengthen its geographic reach and enhance its product portfolio.

The varicose vein treatment market in North America and Europe is expected to grow at a CAGR of 6.9% from 2016 to 2021. Analysis of the market developments between 2013 and 2016 reveals that new product launches and acquisitions were the most important growth strategies followed by key market players. These strategies were adopted by major players such as Medtronic plc (Ireland); AngioDynamics, Inc. (U.S.); biolitec AG (Austria); Syneron Medical Ltd. (Israel); Lumenis Ltd. (Israel) during the period of 2013 - 2016.
Download PDF Brochure: @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=22524107
Don’t miss out on business opportunities in Esoteric Testing Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]